The 34 rating InvestorsObserver gives to Karuna Therapeutics Inc (KRTX) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 20 percent of stocks in the Biotechnology industry, KRTXs 34 overall rating means the stock scores better than 34 percent of all stocks.

Click Here to get the full Stock Score Report on Karuna Therapeutics Inc (KRTX) Stock.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 34 means the stock is more attractive than 34 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Karuna Therapeutics Inc (KRTX) stock is trading at $94.97 as of 9:56 AM on Thursday, Jan 23, a decline of -$20.30, or -17.61% from the previous closing price of $115.27. The stock has traded between $91.00 and $96.95 so far today. Volume today is less active than usual. So far 381,777 shares have traded compared to average volume of 625,971 shares.

To see InvestorsObserver's Sentiment Score for Karuna Therapeutics Inc click here.

Read more:
Is Karuna Therapeutics Inc (KRTX) a Winner or a Loser in the Biotechnology Industry - InvestorsObserver